Axsome Therapeutics, Inc.
AXSM
शेयरों में रैंक
#2358
Axsome Therapeutics, Inc. is a biopharmaceutical company dedicated to... Axsome Therapeutics, Inc. is a biopharmaceutical company dedicated to discovering and advancing innovative treatments for a range of central nervous system (CNS) disorders within the United States. Its robust product pipeline features several promising candidates, including: AXS-05, an investigational therapy currently being developed for major depressive disorder and treatment-resistant depression. This compound is also in Phase III clinical evaluation for Alzheimer's disease agitation and has successfully finished Phase II trials investigating its use for smoking cessation. AXS-07, a novel, orally administered, rapidly-acting investigational medicine that employs multiple mechanisms of action. It has concluded two Phase III studies for the acute treatment of migraine attacks. AXS-12, a selective and potent norepinephrine reuptake inhibitor, which is presently undergoing a Phase III trial for narcolepsy. AXS-14, an oral investigational drug, advancing through Phase III trials for the management of fibromyalgia. Axsome Therapeutics also engages in a research collaboration with Duke University to further assess AXS-05's potential in smoking cessation. The company, established in 2012, has its main offices in New York, New York.
शेयर मूल्य
$159.65
अंतिम समन्वयन: 2026-10-20
मार्केट कैप
$8.36B
बदलाव (1 दिन)
2.46%
बदलाव (1 वर्ष)
21.51%
देश
US
व्यापार Axsome Therapeutics, Inc. (AXSM)
श्रेणी
Healthcare
Axsome Therapeutics, Inc. (AXSM) के लिए P/S अनुपात
October 2026 को P/S अनुपात TTM: 10.75
Axsome Therapeutics, Inc. की नवीनतम वित्तीय रिपोर्ट और शेयर मूल्य के अनुसार, कंपनी का वर्तमान P/S अनुपात (TTM) 10.75 है। 2023 के अंत में, कंपनी का P/S अनुपात 13.36 था।
Axsome Therapeutics, Inc. के लिए 2013 से 2026 तक P/S अनुपात का इतिहास
हर वर्ष के अंत में P/S अनुपात
| वर्ष | P/S अनुपात | परिवर्तन |
|---|---|---|
| 2026 (TTM) | 10.75 | 2.28% |
| 2024 | 10.51 | -21.33% |
| 2023 | 13.36 | -78.68% |
| 2022 | 62.67 | 0.00% |
| 2021 | 0.00 | 0.00% |
| 2020 | 0.00 | 0.00% |
| 2019 | 0.00 | 0.00% |
| 2018 | 0.00 | 0.00% |
| 2017 | 0.00 | 0.00% |
| 2016 | 0.00 | 0.00% |
| 2015 | 0.00 | 0.00% |
| 2014 | 0.00 | 0.00% |
| 2013 | 0.00 | 0.00% |
समान कंपनियों या प्रतिस्पर्धियों के लिए P/S अनुपात
| कंपनी | P/S अनुपात | P/S अनुपात में अंतर | देश |
|---|---|---|---|
| 10.02 | -6.77% |
US
|
|
| 40.55 | 277.23% |
US
|
|
| 3.96 | -63.15% |
AU
|
|
| 10.15 | -5.61% |
NL
|
|
| - | - |
CH
|
